Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate PressReach · Jun 24, 2022
New to The Street TV Announces Four Business Interviews Airing on the Fox Business Network, Tonight, Wednesday, June 22, 2022, at 11:00 PM PT PressReach · Jun 22, 2022
Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference PressReach · Jun 22, 2022
Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference PressReach · Jun 21, 2022
Welltower Announces Upsizing and Extension of $5.2 Billion Unsecured Credit Facility PressReach · Jun 16, 2022
Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Advanced Development Center (ADC) for Vaccine Programs in Massachusetts PressReach · Jun 16, 2022
Phexxi® Prevented 99% of Pregnancies Per Act of Intercourse in a Post Hoc Analysis of Phase 3 AMPOWER Clinical Trial Data PressReach · Jun 16, 2022
BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies PressReach · Jun 15, 2022
Kintara Therapeutics Granted Fast Track Designation from the FDA for VAL-083 for Newly-Diagnosed Glioblastoma PressReach · Jun 15, 2022
Quoin Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement PressReach · Jun 15, 2022
Evoke Pharma Announces Approval of GIMOTI® to Florida State Medicaid Program PressReach · Jun 15, 2022
Quoin Pharmaceuticals Announces Licensing and Distribution Agreement with Leading Rare Disease Company for Greater China PressReach · Jun 15, 2022
